Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease
Inflammatory Bowel Diseases · 03.07.2024 · 30 (7) · 1220-1222
DOI: 10.1093/ibd/izae078 ↗Kurz gefasst
Fallbericht in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 08.04.2024. Verfasst von Itaru Iwama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Remission Induction, Ustekinumab. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lay Summary We observed efficacy and safety of ustekinumab in very early-onset inflammatory bowel disease, which has not been previously reported. Clinical remission at 52% was 75%, often persisting beyond 2 years. Further studies including larger numbers of cases are needed to confirm this observation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.
ORCID-Profile: Itaru Iwama, Ryusuke Nambu
Zitieren
APA
Iwama, I., Yoshida, M., Miyazawa, A., Hara, T., & Nambu, R. (2024). Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 30(7), 1220-1222. https://doi.org/10.1093/ibd/izae078
Vancouver
Iwama I, Yoshida M, Miyazawa A, Hara T, Nambu R. Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2024;30(7):1220-1222. doi:10.1093/ibd/izae078
BibTeX
@article{Iwama2024,
author = {Iwama, Itaru and Yoshida, Masashi and Miyazawa, Ayako and Hara, Tomoko and Nambu, Ryusuke},
title = {Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease},
journal = {Inflammatory Bowel Diseases},
year = {2024},
volume = {30},
number = {7},
pages = {1220--1222},
doi = {10.1093/ibd/izae078}
}
EUVIMED